Cargando…

Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)

INTRODUCTION: Studies in mammary cancer demonstrated that moderately high concentrations of molecular iodine (I(2)) have a antiproliferative and apoptotic effect either in vivo as in vitro, however the cellular intermediated involved in these effects has not been elucidated. METHODS: Virgin Sprague-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aceves, Carmen, García-Solís, Pablo, Arroyo-Helguera, Omar, Vega-Riveroll, Laura, Delgado, Guadalupe, Anguiano, Brenda
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703618/ https://www.ncbi.nlm.nih.gov/pubmed/19500378 http://dx.doi.org/10.1186/1476-4598-8-33

Ejemplares similares

Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection
por: Alfaro, Yunuen, et al.
Publicado: (2013)

Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone
por: Nava-Villalba, Mario, et al.
Publicado: (2015)

Molecular iodine exerts antineoplastic effects by diminishing proliferation and invasive potential and activating the immune response in mammary cancer xenografts
por: Mendieta, Irasema, et al.
Publicado: (2019)

Enantioselective iodolactonization to prepare ε-lactone rings using hypervalent iodine
por: Payne, Jenna L., et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors
por: Tatenhorst, Lars, et al.
Publicado: (2008)

Molecular Iodine Has Extrathyroidal Effects as an Antioxidant, Differentiator, and Immunomodulator
por: Aceves, Carmen, et al.
Publicado: (2021)

Molecular Iodine/Cyclophosphamide Synergism on Chemoresistant Neuroblastoma Models
por: Álvarez-León, Winniberg, et al.
Publicado: (2021)

Molecular Iodine Supplement Prevents Streptozotocin-Induced Pancreatic Alterations in Mice
por: Rodríguez-Castelán, Julia, et al.
Publicado: (2022)

Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer
por: Zambrano-Estrada, Xóchitl, et al.
Publicado: (2018)

Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study
por: Moreno-Vega, Aura, et al.
Publicado: (2019)

Effects of Molecular Iodine/Chemotherapy in the Immune Component of Breast Cancer Tumoral Microenvironment
por: Cuenca-Micó, Olga, et al.
Publicado: (2021)

Preventive Effect of Molecular Iodine in Pancreatic Disorders from Hypothyroid Rabbits
por: Rodríguez-Castelán, Julia, et al.
Publicado: (2023)

Antineoplastics: Multisystem toxicities: 6 case reports
Publicado: (2020)

Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
por: Cellai, I, et al.
Publicado: (2006)

The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ
por: Rousseaux, Christel, et al.
Publicado: (2013)

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
por: Vella, Veronica, et al.
Publicado: (2017)

Iodine induces toxicity against Candida albicans and Candida glabrata through oxidative stress
por: Cuellar-Rufino, Sergio, et al.
Publicado: (2022)

The Effect of Antineoplastic Drugs in a Male Spontaneous Mammary Tumor Model
por: Shishido, Stephanie N., et al.
Publicado: (2013)

Constrained Dipeptide Surrogates: 5- and 7-Hydroxy Indolizidin-2-one Amino Acid Synthesis from Iodolactonization of Dehydro-2,8-diamino Azelates
por: Mulamreddy, Ramakotaiah, et al.
Publicado: (2021)

Iodine a Preventive of Mammary Abscess
por: Stewart, H. C.
Publicado: (1853)

PPARα-mediated peroxisome induction compensates PPARγ-deficiency in bronchiolar club cells
por: Karnati, Srikanth, et al.
Publicado: (2018)

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders
por: Cho, Min-Chul, et al.
Publicado: (2008)

Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis
por: Cardell, Lars-Olaf, et al.
Publicado: (2005)

The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer
por: Huang, Runzhi, et al.
Publicado: (2020)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
por: Peng, Lin, et al.
Publicado: (2021)

Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects
por: Robles-Bañuelos, Benjamín, et al.
Publicado: (2022)

Prostate gland as a target organ of thyroid hormones: advances and controversies
por: Anguiano, Brenda, et al.
Publicado: (2022)

Expression of the Peroxisome Proliferator-Activated Receptors (PPARs) in the Hepatic Stellate Cells
por: Sato, Takeya, et al.
Publicado: (2004)

Peroxisome Proliferator-Activated Receptor (PPAR): Balance for Survival in Parasitic Infections
por: Chan, Marion M., et al.
Publicado: (2010)

Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis
por: Ferret-Sena, Véronique, et al.
Publicado: (2018)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice
por: Michalik, Liliane, et al.
Publicado: (2001)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

Peroxisome proliferator-activated receptors (PPARα, PPARγ and PPARβ/δ) gene expression profile on ram spermatozoa and their relation to the sperm motility
por: Kadivar, Ali, et al.
Publicado: (2016)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) in vitro
por: Alexander, Stephen PH, et al.
Publicado: (2012)

PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2014)

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders
por: Ren, Ping, et al.
Publicado: (2015)

Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
por: Gou, Qian, et al.
Publicado: (2017)

Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα
por: Tahri-Joutey, Mounia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1c30ufgbmhp0hi3l9i90gjiu0k